| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | BEIGENE LTD | 116,707 | 3,421,000 | 0.15% | ||
| 102 | AURIS MED HLDG AG | 834,263 | 3,037,000 | 0.13% | ||
| 103 | UNIQURE NV | 241,021 | 2,863,000 | 0.12% | ||
| 104 | IMMUNOMEDICS INC | 4,000,000 | 2,810,000 | 0.12% | PRN | |
| 105 | NEVRO CORP | 49,800 | 2,802,000 | 0.12% | ||
| 106 | DEPOMED INC | 200,000 | 2,786,000 | 0.12% | ||
| 107 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 811,227 | 2,783,000 | 0.12% | ||
| 108 | CELATOR PHARMACEUTICALS INC | 236,000 | 2,603,000 | 0.11% | ||
| 109 | GRIFOLS S A SP ADR REP B | 166,000 | 2,568,000 | 0.11% | ||
| 110 | ADAPTIMMUNE THERAPEUTICS PLC | 296,934 | 2,414,000 | 0.10% | ||
| 111 | LEXICON PHARMACEUTICALS | 197,641 | 2,362,000 | 0.10% | ||
| 112 | FLEX PHARMA INC COM | 212,600 | 2,332,000 | 0.10% | ||
| 113 | FORWARD PHARMA A/S | 136,547 | 2,321,000 | 0.10% | ||
| 114 | ALLSCRIPTS HEALTHCARE | 173,600 | 2,293,000 | 0.10% | ||
| 115 | CARE CAP PPTYS INC | 84,316 | 2,263,000 | 0.10% | ||
| 116 | INSMED INC COM PAR .01 | 178,600 | 2,263,000 | 0.10% | ||
| 117 | MERRIMACK PHARMACEUTI | 1,485,000 | 2,205,000 | 0.09% | PRN | |
| 118 | AMICUS THERAPEUTICS INC | 258,000 | 2,180,000 | 0.09% | ||
| 119 | CYNAPSUS THERAPEUTICS INC | 180,407 | 2,147,000 | 0.09% | ||
| 120 | DBV TECHNOLOGIES | 65,600 | 2,135,000 | 0.09% | ||
| 121 | BLUEBIRD BIO INCORPORATED | 49,345 | 2,097,000 | 0.09% | ||
| 122 | HALOZYME THERAPEUTICS INC | 200,000 | 1,894,000 | 0.08% | ||
| 123 | KITE PHARMA INCORPORATED | 41,000 | 1,882,000 | 0.08% | ||
| 124 | NOVAVAX INC COM | 358,000 | 1,847,000 | 0.08% | ||
| 125 | Esperion Therapeutics Inc | 102,800 | 1,738,000 | 0.07% | ||
| 126 | CHIMERIX INC | 308,892 | 1,578,000 | 0.07% | ||
| 127 | Momenta Pharmaceuticals Inc | 153,700 | 1,420,000 | 0.06% | ||
| 128 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 1,353,000 | 0.06% | ||
| 129 | AFFIMED N V | 294,213 | 1,100,000 | 0.05% | ||
| 130 | CIDARA THERAPEUTICS INC | 72,500 | 921,000 | 0.04% | ||
| 131 | TETRAPHASE PHARMACEUTICALS I COM | 192,322 | 890,000 | 0.04% | ||
| 132 | GALAPAGOS NV | 20,000 | 836,000 | 0.04% | ||
| 133 | REVANCE THERAPEUTICS INC COM | 45,000 | 786,000 | 0.03% | ||
| 134 | BELLICUM PHARMACEUTICALS INC COM | 60,000 | 561,000 | 0.02% | ||
| 135 | GENMARK DIAGNOSTICS INC COM | 93,349 | 492,000 | 0.02% | ||
| 136 | CELLDEX THERAPEUTICS INC NEW | 105,800 | 400,000 | 0.02% | ||
| 137 | XENCOR INC COM | 20,000 | 268,000 | 0.01% | ||
| 138 | RMR GROUP INC | 7,441 | 186,000 | 0.01% | ||
| 139 | ZAFGEN INC COM | 13,307 | 89,000 | 0.00% | ||
| 140 | ABBVIE INC | 156 | 9,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-119071, filed 2016.05.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
